CONCLUSIONS: Here we summarize current data on clinical diagnostic measures, antiviral therapy, and known factors of human host biology that contribute to the distinct neonatal outcomes of HSV infection.
RESULTS: We then explore recent new data on how viral genetic diversity between infections may impact clinical outcomes. Further research will be critical to build upon these early findings and to provide statistical power to our ability to discern and/or predict the potential clinical path of a given neonatal infection.
结论:在这里,我们总结了有关临床诊断措施的现有数据,抗病毒治疗,以及导致HSV感染的不同新生儿结局的人类宿主生物学已知因素。
结果:然后,我们探讨了最近的新数据,即感染之间的病毒遗传多样性如何影响临床结果。进一步的研究对于建立这些早期发现并为我们辨别和/或预测给定新生儿感染的潜在临床路径的能力提供统计能力至关重要。